PRFX (painreform.com) Bozor qiymatining balans qiymatiga nisbati

PainReform Ltd (PRFX) kompaniyasining rasmiy ramzlari

PainReform Ltd. (PRFX) kompaniyasining istiqbollari tartibga soluvchi organlarning tasdiqlari va og'riqni boshqarishning cho'zilgan ta'sirga ega tizimlari samaradorligiga bog'liq. Ushbu P/BV grafigi aktivlar qiymati dinamikasini vizuallashtiradi, bunda 0.14 ushbu ko'rsatkichning joriy qiymatini ifodalaydi. Biznesning o'sishi PRF-110 platformasini jarrohlik protokollariga integratsiya qilishga hamda tashqi sotib olishlarsiz, shifoxona savdo tarmog'i doirasida organik kengayish strategiyasiga tayanadi.

PRFX PainReform Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 27.10.2026 oraligʻida

PainReform Ltd (PRFX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari PainReform Ltd.|PRFX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati PainReform Limited|PRFX - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati PainReform|PRFX - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati painreform.com|PRFX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati PainReform Ltd.|PRFX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati PainReform Limited|PRFX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar PainReform Limited
Kompaniyaning dastlabki tahlili:PainReform Ltd. - PRFX
PainReform Limited original mahsuloti

Ushbu ko'rsatkich fundamental tendentsiyaning kuchini tasdiqlash uchun biznesning joriy bozor qiymatini uning sof aktivlari bilan solishtiradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati ko'rsatkichi grafigini tahlil qilish orqali investor kompaniyaning bozor tomonidan qayta baholanishi qanchalik silliq kechayotganini baholaydi. Ushbu metrika buxgalteriya qiymati va bozor kutganlari o'rtasidagi farqni o'lchab, qarzga nisbatan yashirin zaiflikni ochib beradi. PainReform Ltd. (PRFX) uchun ushbu farq kelajakdagi FDA tasdiqlari spekulyativ qiymatini aks ettiradi. Isroil boshqaruvining R&D sohasidagi kompetentsiyasi va pipeline shaffofligi bunday bozor premiumlarini asosli qiladi.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|MindWalk Holdings Inc. (HYFT) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ABVC BioPharma Inc. ABVC|Cumberland Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|QNTM - Bozor kapitallashuvining balans qiymatiga nisbati|FibroGen, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|TELO (telomirpharma.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Rani Therapeutics Holdings (RANI)|Kapitallashuvning balans qiymatiga nisbati SNYR|Rallybio Corporation (RLYB) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati lexariabioscience.com (LEXX)|PULM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Pheton Holdings Limited PTHL|Bozor kapitallashuvining balans qiymatiga nisbati Aptorum|LYRA: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati IBO|TNFA (TNF Pharmaceuticals, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|YCBD - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CYTO|Bozor qiymatining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OptiNose Inc OPTN|Kapitallashuvning sof aktivlarga nisbati Pieris|Procaps Group Corp - Balans qiymatiga nisbatan bozor qiymati|PTPI - Bozor qiymatining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor qiymatining balans qiymatiga nisbati|SLRN - Kapitallashuvning sof aktivlarga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga multiplikatori